Sanjay Maraboyina
Associate Professor
University of Arkansas for Medical Sciences
faculty
Radiation Oncology, College of Medicine
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Dr. Sanjay Maraboyina's research focuses on aspects of radiation oncology and patient outcomes. He has investigated health care disparities and barriers to palliative care among patients with metastatic renal cell carcinoma, analyzing data from the National Cancer Database. His work also extends to understanding the facilitators and barriers to employment for rural women cancer survivors. Previously, Dr. Maraboyina has conducted research on the effects of brachytherapy for prostate cancer and the impact of insulin and glucocorticoids on the cell cycle. His publications include abstracts in the International Journal of Radiation Oncology and presentations at the American Society of Hematology Annual Meeting. Dr. Maraboyina holds an h-index of 9 with 29 total publications and 246 total citations. He collaborates with researchers at the University of Arkansas for Medical Sciences and the University of Arkansas at Fayetteville.
Research Overview
Dr. Sanjay Maraboyina is an Assistant Professor in the Radiation Oncology Department at the UAMS College of Medicine, and is board certified by the American Board of Radiology. He received his medical degree from Drexel University College of Medicine. Dr. Maraboyina went on to complete an internship in internal medicine at Christ Hospital in Cincinnati, Ohio and a Radiation Oncology residency at the University of Kansas Medical Center. He also completed a Prostate Brachytherapy Scholarship at the MD Anderson Cancer Center in Houston.Dr. Maraboyina has done research work on a number of topics, including the effects of brachytherapy for prostate cancer and the effects of insulin and glucocorticoids on the cell cycle. His publications include abstracts in the International Journal of Radiation Oncology, the official journal of the American Society for Radiation Oncology (ASTRO), as well as presenting an abstact at the American Society of Hematology Annual Meeting.
Metrics
- h-index: 9
- Publications: 29
- Citations: 246
Selected Publications
Grants & Funding
- No FP attached NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation Principal Investigator
- Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*) (273360) NRG Oncology Foundation Principal Investigator
- NRG-GU012 - Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI) NRG Oncology Foundation Principal Investigator
- No FP attached NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation Principal Investigator
- No FP attached NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation Principal Investigator
- 297182 Title NRG-GU013, “The Phase III ‘High Five Trial’ Five Fraction Radiation For High-Risk Prostate Cancer” NRG Oncology Foundation Principal Investigator
- 297182 Title NRG-GU013, “The Phase III ‘High Five Trial’ Five Fraction Radiation For High-Risk Prostate Cancer” NRG Oncology Foundation Principal Investigator
- No FP attached NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation Principal Investigator
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics